Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-20

Clinical Trial Update: Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating adherence with continuous-dose oral contraceptive in self-selection and use.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: HRA Pharma | Conditions: Contraception | Phase 3 | Status: COMPLETED